SLC22 Antibodies

Santa Cruz Biotechnology features a diverse variety of SLC22 monoclonal antibodies for studying solute carrier family 22 proteins. SLC22 monoclonal antibodies are validated for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SLC22 proteins facilitate the transport of organic cations, anions, and neutral compounds across cell membranes, influencing pharmacokinetics and drug disposition. Their function is essential in processes such as renal clearance and the uptake of neurotransmitters, making them significant in studies related to drug interactions and metabolic disorders. Understanding SLC22 proteins can provide insights into therapeutic targets for various diseases. Researchers worldwide rely on SLC22 monoclonal antibodies to advance their studies in membrane transport mechanisms. Current investigations focus on how SLC22 proteins influence drug absorption and distribution across different tissues. Ongoing research explores the relationship between SLC22 proteins and various pathological conditions. Santa Cruz Biotechnology monoclonal antibodies for SLC22 proteins enable researchers to make meaningful contributions to the scientific understanding of membrane transport and drug development.